Home›Companies›Healthcare›Levee Medical

Levee Medical, Inc.

Develops an investigational implant to address urinary incontinence after prostate cancer surgery.

Updated Nov 10, 2026·Latest SEC filing May 5, 2026·Suggest an edit

About Levee Medical

Levee Medical is a private company based in Durham, North Carolina. It has reported $28,304,055 raised in five offerings on Form D since August 2021. Its chief executive is Adam Irving.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Oct 31, 2025Nov 12, 2025amended May 5, 2026$12,500,000fully sold130$96,154DebtRule 506(b)Form D/A ↗1 earlier filing
Jul 31, 2024Aug 15, 2024$6,506,523of $10.0M target70$92,950EquityRule 506(b)Form D ↗
Jun 23, 2023Jul 7, 2023$3,447,526of $4.3M target34$101KDebtRule 506(b)Form D ↗
Mar 31, 2022Apr 15, 2022amended Jul 13, 2022$3,250,006of $4.0M target54$60,185EquityRule 506(b)Form D/A ↗1 earlier filing
Aug 9, 2021Aug 24, 2021amended Jan 21, 2022$2,600,000fully sold49$53,061DebtRule 506(b)Form D/A ↗1 earlier filing
Total, five offerings$28,304,055

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on Levee Medical's Form D filed May 5, 2026.

Bruce Choi
Bruce Choi
Founder, Director, CTO & Chairman
Gary McCord
Gary McCord
Director
Mike Henson
Mike Henson
Director
Adam Irving
Adam Irving
CEO & Director

Sources

  1. SECLevee Medical, Inc. Form D, filed Nov 12, 2025
  2. SECLevee Medical, Inc. Form D, filed Apr 15, 2022
  3. SECLevee Medical, Inc. Form D, filed Aug 24, 2021
  4. SECLevee Medical, Inc. filing history